Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2012, Volume 130, Issue 5, pp. 1049 - 1062
Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic...
Allergy and Immunology | allergy | GRADE | asthma | Rhinitis | Allergic Rhinitis and its Impact on Asthma | MANAGEMENT | GUIDELINES | VALIDATION | CLASSIFICATION | INTERMITTENT | PREVALENCE | IMMUNOLOGY | WORLD-HEALTH-ORGANIZATION | COLLABORATION | UPDATE | QUALITY-OF-LIFE | World Health Organization | Rhinitis, Allergic, Seasonal - classification | Rhinitis, Allergic, Seasonal - complications | Europe | Humans | Clinical Trials as Topic | Rhinitis, Allergic, Perennial - classification | Rhinitis, Allergic, Perennial - complications | Rhinitis, Allergic, Perennial - epidemiology | Rhinitis, Allergic, Seasonal - epidemiology | Animals | Asthma - complications | Asthma - classification | Child | Asthma - epidemiology | Practice Guidelines as Topic | Evidence, Expert | Allergens | Antihistamines | Rheumatoid factor | Asthma in children | Family medicine | Research institutes | Consulting services | Public health | Studies | Disease | Preschool children | Comorbidity | Classification | Primary care | Allergies | Quality of life | Conferences | Allergic rhinitis | Hypersensitivity | Children | Age | Asthma
Allergy and Immunology | allergy | GRADE | asthma | Rhinitis | Allergic Rhinitis and its Impact on Asthma | MANAGEMENT | GUIDELINES | VALIDATION | CLASSIFICATION | INTERMITTENT | PREVALENCE | IMMUNOLOGY | WORLD-HEALTH-ORGANIZATION | COLLABORATION | UPDATE | QUALITY-OF-LIFE | World Health Organization | Rhinitis, Allergic, Seasonal - classification | Rhinitis, Allergic, Seasonal - complications | Europe | Humans | Clinical Trials as Topic | Rhinitis, Allergic, Perennial - classification | Rhinitis, Allergic, Perennial - complications | Rhinitis, Allergic, Perennial - epidemiology | Rhinitis, Allergic, Seasonal - epidemiology | Animals | Asthma - complications | Asthma - classification | Child | Asthma - epidemiology | Practice Guidelines as Topic | Evidence, Expert | Allergens | Antihistamines | Rheumatoid factor | Asthma in children | Family medicine | Research institutes | Consulting services | Public health | Studies | Disease | Preschool children | Comorbidity | Classification | Primary care | Allergies | Quality of life | Conferences | Allergic rhinitis | Hypersensitivity | Children | Age | Asthma
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 126, Issue 5, pp. 926 - 938
Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic groups and countries. It is estimated that around 250,000 people...
Allergy and Immunology | severity | control | risk | definition | GARD | Asthma | Definition | Risk | Control | Severity | RESPONSIVENESS | LOW-INCOME | LUNG-FUNCTION | INHALED CORTICOSTEROIDS | FOLLOW-UP | PHENOTYPES | IMMUNOLOGY | CHILDHOOD ASTHMA | CLUSTER-ANALYSIS | PRESCHOOL-CHILDREN | ALLERGY | HIGH-RISK | Clinical Trials as Topic | World Health Organization | Asthma - classification | Humans | Allergy | Medical colleges | Corticosteroids | International cooperation | Asthma in children | Respiratory agents | Allergic reaction | Public health | Task forces | Tuberculosis | Pulmonary arteries | Clinical trials | Patients
Allergy and Immunology | severity | control | risk | definition | GARD | Asthma | Definition | Risk | Control | Severity | RESPONSIVENESS | LOW-INCOME | LUNG-FUNCTION | INHALED CORTICOSTEROIDS | FOLLOW-UP | PHENOTYPES | IMMUNOLOGY | CHILDHOOD ASTHMA | CLUSTER-ANALYSIS | PRESCHOOL-CHILDREN | ALLERGY | HIGH-RISK | Clinical Trials as Topic | World Health Organization | Asthma - classification | Humans | Allergy | Medical colleges | Corticosteroids | International cooperation | Asthma in children | Respiratory agents | Allergic reaction | Public health | Task forces | Tuberculosis | Pulmonary arteries | Clinical trials | Patients
Journal Article
European Journal of Epidemiology, ISSN 0393-2990, 5/2019, Volume 34, Issue 5, pp. 509 - 520
Asthma prevalence in children varies substantially around the world, but the contribution of known risk factors to this international variation is uncertain....
Environmental risk factors | Public Health | Medicine & Public Health | International variation | Hypersensitivity | Infectious Diseases | Oncology | Cardiology | Epidemiology | Child | Asthma | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SYMPTOMS | ATOPY | CHILDREN | Allergy | Wheeze | Asthma in children | Analysis | Allergic reaction | Testing | Environmental factors | Risk analysis | Environmental risk | Risk factors | Allergies | Atopy | Ecological risk assessment | Stoves | Ecological effects | Reduction | Moisture content | Pillows | Skin | Children | Variation | Skin tests | Smoking
Environmental risk factors | Public Health | Medicine & Public Health | International variation | Hypersensitivity | Infectious Diseases | Oncology | Cardiology | Epidemiology | Child | Asthma | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SYMPTOMS | ATOPY | CHILDREN | Allergy | Wheeze | Asthma in children | Analysis | Allergic reaction | Testing | Environmental factors | Risk analysis | Environmental risk | Risk factors | Allergies | Atopy | Ecological risk assessment | Stoves | Ecological effects | Reduction | Moisture content | Pillows | Skin | Children | Variation | Skin tests | Smoking
Journal Article
4.
Full Text
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper
Allergy, ISSN 0105-4538, 2010, Volume 65, Issue 10, pp. 1212 - 1221
The links between asthma and rhinitis are well characterized. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines stress the importance of these...
EAACI | EFA | ARIA | asthma | rhinitis | IPCRG | GA2LEN | STATEMENT | DIAGNOSIS | SEVERE ASTHMA | MANAGEMENT | CLASSIFICATION | STRENGTH | PREVALENCE | IMMUNOLOGY | PRIMARY-CARE | ALLERGY | NONALLERGIC RHINITIS | GRADING QUALITY | Rhinitis, Allergic, Perennial - prevention & control | Rhinitis, Allergic, Seasonal - prevention & control | Planning Techniques | Rhinitis, Allergic, Seasonal - therapy | Asthma - prevention & control | Humans | Rhinitis, Allergic, Perennial - therapy | Asthma - therapy | Disease Management | Evidence-Based Medicine | Practice Guidelines as Topic | Allergies | Disease management | Asthma | Dopamine | Allergic rhinitis | Hypersensitivity | Yawning behavior | Stress | Immunology in the medical area | Immunologi inom det medicinska området
EAACI | EFA | ARIA | asthma | rhinitis | IPCRG | GA2LEN | STATEMENT | DIAGNOSIS | SEVERE ASTHMA | MANAGEMENT | CLASSIFICATION | STRENGTH | PREVALENCE | IMMUNOLOGY | PRIMARY-CARE | ALLERGY | NONALLERGIC RHINITIS | GRADING QUALITY | Rhinitis, Allergic, Perennial - prevention & control | Rhinitis, Allergic, Seasonal - prevention & control | Planning Techniques | Rhinitis, Allergic, Seasonal - therapy | Asthma - prevention & control | Humans | Rhinitis, Allergic, Perennial - therapy | Asthma - therapy | Disease Management | Evidence-Based Medicine | Practice Guidelines as Topic | Allergies | Disease management | Asthma | Dopamine | Allergic rhinitis | Hypersensitivity | Yawning behavior | Stress | Immunology in the medical area | Immunologi inom det medicinska området
Journal Article
Clinical & Experimental Allergy, ISSN 0954-7894, 04/2019, Volume 49, Issue 4, pp. 430 - 441
Background Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) measured the global prevalence of symptoms of asthma in...
environment and hygiene hypothesis | epidemiology | asthma | ECZEMA | RATIONALE | GLOBAL FINDINGS | SYMPTOMS | PREVALENCE | IMMUNOLOGY | CHILDREN | ALLERGY | RHINOCONJUNCTIVITIS | ASSOCIATION | EXPOSURE | INFANCY | Allergy | Medical research | Asthma in children | Medicine, Experimental | Allergic reaction | Epidemiology | Risk factors | Adolescence | Signs and symptoms | Cooking | Statistical analysis | Causation | Exposure | Regression analysis | Risk analysis | Environmental risk | Allergies | Asthma | Ecological risk assessment | Confidence intervals | Ecological effects | Tobacco | Paracetamol | Antibiotics | Analgesics | Ecological monitoring | Children | Causality | Schools | ORIGINAL ARTICLES | Original
environment and hygiene hypothesis | epidemiology | asthma | ECZEMA | RATIONALE | GLOBAL FINDINGS | SYMPTOMS | PREVALENCE | IMMUNOLOGY | CHILDREN | ALLERGY | RHINOCONJUNCTIVITIS | ASSOCIATION | EXPOSURE | INFANCY | Allergy | Medical research | Asthma in children | Medicine, Experimental | Allergic reaction | Epidemiology | Risk factors | Adolescence | Signs and symptoms | Cooking | Statistical analysis | Causation | Exposure | Regression analysis | Risk analysis | Environmental risk | Allergies | Asthma | Ecological risk assessment | Confidence intervals | Ecological effects | Tobacco | Paracetamol | Antibiotics | Analgesics | Ecological monitoring | Children | Causality | Schools | ORIGINAL ARTICLES | Original
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 09/2007, Volume 176, Issue 6, pp. 565 - 574
Rationale: Atopic sensitization has long been known to be related to asthma in children, but its role in determining asthma prevalence remains to be elucidated...
Gross national income per capita | ISAAC Phase Two | Wheeze | Population attributable risk | IgE | BRONCHIAL HYPERRESPONSIVENESS | RISK-FACTORS | SEMIRURAL AREA | wheeze | ALLERGEN EXPOSURE | CHILDHOOD ISAAC | gross national income per capita | population attributable risk | SCHOOLCHILDREN | RESPIRATORY SYSTEM | RESPIRATORY SYMPTOMS | DIFFERENT PATTERN | LIFE | CRITICAL CARE MEDICINE | Prevalence | Prognosis | Cross-Sectional Studies | Global Health | Humans | Risk Factors | Antibodies, Anti-Idiotypic - immunology | Urban Population | Socioeconomic Factors | Immunoglobulin E - immunology | Rural Population | Asthma - immunology | Hypersensitivity, Immediate - epidemiology | Hypersensitivity, Immediate - immunology | Odds Ratio | Child | Asthma - epidemiology | Immunoglobulin E | Hypersensitivity, Immediate | Asthma | Life Sciences | World Health | Santé publique et épidémiologie | Antibodies, Anti-Idiotypic
Gross national income per capita | ISAAC Phase Two | Wheeze | Population attributable risk | IgE | BRONCHIAL HYPERRESPONSIVENESS | RISK-FACTORS | SEMIRURAL AREA | wheeze | ALLERGEN EXPOSURE | CHILDHOOD ISAAC | gross national income per capita | population attributable risk | SCHOOLCHILDREN | RESPIRATORY SYSTEM | RESPIRATORY SYMPTOMS | DIFFERENT PATTERN | LIFE | CRITICAL CARE MEDICINE | Prevalence | Prognosis | Cross-Sectional Studies | Global Health | Humans | Risk Factors | Antibodies, Anti-Idiotypic - immunology | Urban Population | Socioeconomic Factors | Immunoglobulin E - immunology | Rural Population | Asthma - immunology | Hypersensitivity, Immediate - epidemiology | Hypersensitivity, Immediate - immunology | Odds Ratio | Child | Asthma - epidemiology | Immunoglobulin E | Hypersensitivity, Immediate | Asthma | Life Sciences | World Health | Santé publique et épidémiologie | Antibodies, Anti-Idiotypic
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2011, Volume 183, Issue 2, pp. 171 - 178
Rationale There is epidemiological evidence that the use of acetaminophen may increase the risk of developing asthma. Objectives: To investigate the risk of...
ISAAC | Rhinoconjunctivitis | Acetaminophen | Eczema | Asthma | asthma | VIDEO QUESTIONNAIRE | SYMPTOMS | PARACETAMOL USE | PREVALENCE | CHILDREN | rhinoconjunctivitis | IBUPROFEN | acetaminophen | RESPIRATORY SYSTEM | eczema | WRITTEN QUESTIONNAIRE | ASSOCIATION | EXPOSURE | CRITICAL CARE MEDICINE | Acetaminophen - adverse effects | Conjunctivitis - epidemiology | Cross-Sectional Studies | Global Health | Humans | Risk Factors | Male | Conjunctivitis - chemically induced | Asthma - chemically induced | Eczema - epidemiology | Drug Hypersensitivity - epidemiology | Analgesics, Non-Narcotic - adverse effects | Eczema - chemically induced | Adolescent | Rhinitis - chemically induced | Female | Surveys and Questionnaires | Causality | Odds Ratio | Rhinitis - epidemiology | Asthma - epidemiology | Cohort Studies
ISAAC | Rhinoconjunctivitis | Acetaminophen | Eczema | Asthma | asthma | VIDEO QUESTIONNAIRE | SYMPTOMS | PARACETAMOL USE | PREVALENCE | CHILDREN | rhinoconjunctivitis | IBUPROFEN | acetaminophen | RESPIRATORY SYSTEM | eczema | WRITTEN QUESTIONNAIRE | ASSOCIATION | EXPOSURE | CRITICAL CARE MEDICINE | Acetaminophen - adverse effects | Conjunctivitis - epidemiology | Cross-Sectional Studies | Global Health | Humans | Risk Factors | Male | Conjunctivitis - chemically induced | Asthma - chemically induced | Eczema - epidemiology | Drug Hypersensitivity - epidemiology | Analgesics, Non-Narcotic - adverse effects | Eczema - chemically induced | Adolescent | Rhinitis - chemically induced | Female | Surveys and Questionnaires | Causality | Odds Ratio | Rhinitis - epidemiology | Asthma - epidemiology | Cohort Studies
Journal Article
Bulletin of the World Health Organization, ISSN 0042-9686, 2001, Volume 79, Issue 10, pp. 971 - 979
In developing countries, chronic respiratory diseases represent a challenge to public health because of their frequency, severity, projected trends, and...
Essential drugs | Smoking cessation | Developing countries (source: MeSH) | Cost of illness | Lung diseases, Obstructive/economics/prevention and control/epidemiology | Asthma/economics/prevention and control/epidemiology | CHRONIC-BRONCHITIS | lung diseases | COST-EFFECTIVENESS | ASTHMA MORTALITY | NEW-ZEALAND | essential drugs | asthma/economics/prevention and control/epidemiology | INHALED CORTICOSTEROIDS | SYMPTOMS | obstructive/economics/prevention and control/epidemiology | CHILDHOOD | CHILDREN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | smoking cessation | developing countries | INNER-CITY | cost of illness | LUNG HEALTH | Anti-Asthmatic Agents - economics | Poverty | Asthma - prevention & control | Developing Countries - economics | Developing Countries - statistics & numerical data | Humans | Cost of Illness | Health Priorities | Asthma - drug therapy | Pulmonary Disease, Chronic Obstructive - epidemiology | Asthma - economics | Pulmonary Disease, Chronic Obstructive - prevention & control | Health Care Rationing | Drugs, Essential - supply & distribution | Public Health Practice | Health Policy | Pulmonary Disease, Chronic Obstructive - economics | Disabled Persons | Asthma - epidemiology | Pulmonary Disease, Chronic Obstructive - drug therapy | Smoking Cessation | Respiratory tract diseases | Demographic aspects | Analysis | Prevalence studies (Epidemiology)
Essential drugs | Smoking cessation | Developing countries (source: MeSH) | Cost of illness | Lung diseases, Obstructive/economics/prevention and control/epidemiology | Asthma/economics/prevention and control/epidemiology | CHRONIC-BRONCHITIS | lung diseases | COST-EFFECTIVENESS | ASTHMA MORTALITY | NEW-ZEALAND | essential drugs | asthma/economics/prevention and control/epidemiology | INHALED CORTICOSTEROIDS | SYMPTOMS | obstructive/economics/prevention and control/epidemiology | CHILDHOOD | CHILDREN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | smoking cessation | developing countries | INNER-CITY | cost of illness | LUNG HEALTH | Anti-Asthmatic Agents - economics | Poverty | Asthma - prevention & control | Developing Countries - economics | Developing Countries - statistics & numerical data | Humans | Cost of Illness | Health Priorities | Asthma - drug therapy | Pulmonary Disease, Chronic Obstructive - epidemiology | Asthma - economics | Pulmonary Disease, Chronic Obstructive - prevention & control | Health Care Rationing | Drugs, Essential - supply & distribution | Public Health Practice | Health Policy | Pulmonary Disease, Chronic Obstructive - economics | Disabled Persons | Asthma - epidemiology | Pulmonary Disease, Chronic Obstructive - drug therapy | Smoking Cessation | Respiratory tract diseases | Demographic aspects | Analysis | Prevalence studies (Epidemiology)
Journal Article
9.
Full Text
Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010
Emerging infectious diseases, ISSN 1080-6040, 01/2019, Volume 25, Issue 1, pp. 102 - 111
Antimicrobial drug resistance is a serious health hazard driven by overuse. Administration of antimicrobial drugs to HIV-exposed, uninfected infants, a...
HIV-1 | HIV/AIDS | trimethoprim/sulfamethoxazole drug combination | infectious disease medicine | antibacterial | antibiotic stewardship | infant | antimicrobial resistance | Malawi | antibiotic prophylaxis | drug resistance | poverty | penicillins | CLINICAL OVERLAP | VIRAL LOAD | POPULATION | INFECTIOUS DISEASES | COTRIMOXAZOLE PROPHYLAXIS | DOUBLE-BLIND | OPPORTUNISTIC INFECTIONS | 1ST YEAR | MALARIA | IMMUNOLOGY | ANTIRETROVIRALS | CHILDREN | Medical research | Antiviral agents | Respiratory agents | Infants | Drug resistance | HIV (Viruses) | Breast feeding | Antibacterial agents | Preventive health services | Infection | Highly active antiretroviral therapy | Sulfonamides | Analysis | Medicine, Experimental | Drug therapy | Health aspects | Medicine, Preventive | Physiological aspects | HIV infection in children | Dosage and administration | Antibiotics | Methods | Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004–2010 | AIDS | sulfamethoxazole drug combination | Research | HIV | trimethoprim
HIV-1 | HIV/AIDS | trimethoprim/sulfamethoxazole drug combination | infectious disease medicine | antibacterial | antibiotic stewardship | infant | antimicrobial resistance | Malawi | antibiotic prophylaxis | drug resistance | poverty | penicillins | CLINICAL OVERLAP | VIRAL LOAD | POPULATION | INFECTIOUS DISEASES | COTRIMOXAZOLE PROPHYLAXIS | DOUBLE-BLIND | OPPORTUNISTIC INFECTIONS | 1ST YEAR | MALARIA | IMMUNOLOGY | ANTIRETROVIRALS | CHILDREN | Medical research | Antiviral agents | Respiratory agents | Infants | Drug resistance | HIV (Viruses) | Breast feeding | Antibacterial agents | Preventive health services | Infection | Highly active antiretroviral therapy | Sulfonamides | Analysis | Medicine, Experimental | Drug therapy | Health aspects | Medicine, Preventive | Physiological aspects | HIV infection in children | Dosage and administration | Antibiotics | Methods | Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004–2010 | AIDS | sulfamethoxazole drug combination | Research | HIV | trimethoprim
Journal Article